Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated 1 day ago
AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
1 day ago
Asked by Fierce if he'd consider returning to the FDA, Pazdur said...
Biomarkers are reshaping oncology trial design
1 day ago
Discover how biomarker strategies are transforming oncology trials and accelerating precision medicine...
Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
1 day ago
More than a year after licensing its PD-1xVEGF bispecific, Merck & Co...
UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine
1 day ago
The agreement fulfills several ambitions for UCB. Besides building its epilepsy position...
When Spray Drying Falls Short: A Faster Path Forward
1 day ago
Learn how early intervention can help drug developers convert suboptimal formulations into...
3 bioprocessing trends—and the critical enabler that’s quietly driving them
2 days ago
Bioprocessing is evolving rapidly in a shifting landscape of innovative and complex...
Chutes & Ladders—Metsera acquisition architect swings to Structure
2 days ago
After helping guide Metsera through its high-profile, $10 billion acquisition by Pfizer...
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind
2 days ago
Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a...
Abbott lowers EPS guidance on Exact Sciences buy as shares slide
2 days ago
Abbott is dealing with integrating a big new buyout into its business...
Roivant’s CEO thinks China is a ‘red herring’
2 days ago
China’s biotech rise has been a persistent concern for federal health leaders...
A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
2 days ago
Kailera Therapeutics appears to have set a new benchmark for biotech IPOs...
Small pools, big ideas: How the rare disease community is reimagining clinical trials
2 days ago
The traditional gold standard of clinical trials with a randomized, placebo-controlled design...